Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Blood (2017) 129 (26): 3419–3427.

https://doi.org/10.1182/blood-2017-02-765685

Published: 2017

Includes: Supplemental data

Journal Articles

Clinically Ascertained Monoclonal B-Cell Lymphocytosis: Risk of Progression to Chronic Lymphocytic Leukemia Requiring Therapy and Outcomes

Sameer A. Parikh, MD, Kari G Chaffee, MS, Timothy G. Call, MD, Jose F. Leis, MD, PhD, Wei Ding, MD PhD, Saad S Kenderian, MD, Asher A. Chanan-Khan, MD, Deborah A. Bowen, APRN, CNP, Michael J Conte, PA-C, Susan M. Schwager, Susan L. Slager, PhD, Curtis A. Hanson, MD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2016) 128 (22): 3228.

https://doi.org/10.1182/blood.V128.22.3228.3228

Published: 2016

Journal Articles

The Role of Splenectomy in the Care and Treatment of the CLL Patient

Michael J Conte, PA-C, Sameer A. Parikh, MD, Deborah A. Bowen, APRN, CNP, Timothy G. Call, MD, Brian F Kabat, Kari G Chaffee, MS, Susan M. Schwager, Susan L. Slager, PhD, Wei Ding, MD PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2016) 128 (22): 5575.

https://doi.org/10.1182/blood.V128.22.5575.5575

Published: 2016

Journal Articles

Liver Dysfunction in Previously Untreated Chronic Lymphocytic Leukemia: Prevalence and Outcomes in a Large Cohort

Paul J Hampel, MD, Kari G. Chaffee, MS, Simonetto A Douglas, MD, Timothy G. Call, MD, Wei Ding, MD PhD, Saad S Kenderian, MD, Jose F. Leis, MD, PhD, Asher A. Chanan-Khan, MD, Deborah A. Bowen, APRN, CNP, Michael J Conte, PA-C, Sara J Achenbach, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2016) 128 (22): 5585.

https://doi.org/10.1182/blood.V128.22.5585.5585

Published: 2016

Journal Articles

PD-1 Blockade with Pembrolizumab in Relapsed CLL Including Richter's Transformation: An Updated Report from a Phase 2 Trial (MC1485)

Blood (2016) 128 (22): 4392.

https://doi.org/10.1182/blood.V128.22.4392.4392

Published: 2016

Journal Articles

Tumoral Maximum Standardized Uptake Value > 10 Measured on 18 f-FDG-PET: A New Valid Marker to Discriminate Richter Syndrome

Anne-Sophie Michallet, MD PhD, Pierre P Sesques, Kari G. Rabe, MS, Jeremy Tordot, Christelle Tychyj-Pinel, MD, Baseggio Lucile, Pharm, PhD, Gilles Salles, MDPhD, Jehan Dupuis, MD, Michael J. Conte, PA-C

Blood (2014) 124 (21): 3306.

https://doi.org/10.1182/blood.V124.21.3306.3306

Published: 2014

Journal Articles

An Effective and Tolerable Chemoimmunotherapy Regimen For Relapsed/Refractory and Very-High Risk Chronic Lymphocytic Leukemia Combining Alemtuzumab With Pentostatin and Low Dose Rituximab

Clive S. Zent, MD, Betsy R LaPlant, MS, Wenting Wu, PhD, Timothy G. Call, MD, Deborah Bowen, CNP, Michael J. Conte, PA-C, George J. Weiner, MD, Thomas E Witzig, MD

Blood (2013) 122 (21): 1641.

https://doi.org/10.1182/blood.V122.21.1641.1641

Published: 2013

Journal Articles

The AKT Inhibitor MK2206 In Combination With Rituximab and Bendamustine Is Tolerable and Active In Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results From a Phase 1 Study (NCCTG N1087 Alliance)

Wei Ding, MD, PhD, Tait D Shanafelt, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Betsy R. LaPlant, Timothy G. Call, MD, Curtis A Hanson, MD, Charles Erlichman, MD, Thomas M. Habermann, MD, Craig Reeder, MD, Daniel Nikcevich, Deborah Bowen, CNP, Michael J. Conte, PA-C, Justin Boysen, Charla Secreto, Connie Lesnick, M.Sc, Renee C. Tschumper, Diane F. Jelinek, PhD, Neil E. Kay, MD

Blood (2013) 122 (21): 2882.

https://doi.org/10.1182/blood.V122.21.2882.2882

Published: 2013

Journal Articles

Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab, Rituximab, and PGG Beta Glucan: A Phase I Clinical Trial

Clive S. Zent, MD, Betsy R. LaPlant, Timothy G. Call, MD, Deborah A. Bowen, Michael J. Conte, PA-C, Wei Ding, MD, PhD, George J. Weiner, MD, Thomas E. Witzig, MD

Blood (2012) 120 (21): 1792.

https://doi.org/10.1182/blood.V120.21.1792.1792

Published: 2012

Journal Articles

Clinical Utility of PET/CT Scanning in Patients with Chronic Lymphocytic Leukemia

Michael J. Conte, PA-C, Deborah Bowen, CNP, Kari G. Rabe, MS, Susan Schwager, Susan L Slager, PhD, Clive S. Zent, MD

Blood (2012) 120 (21): 3903.

https://doi.org/10.1182/blood.V120.21.3903.3903

Published: 2012

Journal Articles

Analysis of Stem Cell Transplant Referral in a Cohort of Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Wei Ding, MD, PhD, Kari G. Rabe, MS, Ruchi G. Sharma, Susan Schwager, Susan L Slager, PhD, William J Hogan, MBBCh, Saad J. Sirop, MD, Neil E. Kay, MD, Timothy G Call, MD, Clive S. Zent, MD, Deborah Bowen, CNP, Michael J. Conte, PA-C, Tait D. Shanafelt, MD

Blood (2012) 120 (21): 4252.

https://doi.org/10.1182/blood.V120.21.4252.4252

Published: 2012

NARROW

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Clinically Ascertained Monoclonal B-Cell Lymphocytosis: Risk of Progression to Chronic Lymphocytic Leukemia Requiring Therapy and Outcomes

The Role of Splenectomy in the Care and Treatment of the CLL Patient

Liver Dysfunction in Previously Untreated Chronic Lymphocytic Leukemia: Prevalence and Outcomes in a Large Cohort

PD-1 Blockade with Pembrolizumab in Relapsed CLL Including Richter's Transformation: An Updated Report from a Phase 2 Trial (MC1485)

Tumoral Maximum Standardized Uptake Value > 10 Measured on 18 f-FDG-PET: A New Valid Marker to Discriminate Richter Syndrome

An Effective and Tolerable Chemoimmunotherapy Regimen For Relapsed/Refractory and Very-High Risk Chronic Lymphocytic Leukemia Combining Alemtuzumab With Pentostatin and Low Dose Rituximab

The AKT Inhibitor MK2206 In Combination With Rituximab and Bendamustine Is Tolerable and Active In Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results From a Phase 1 Study (NCCTG N1087 Alliance)

Early Treatment of High Risk Chronic Lymphocytic Leukemia with Alemtuzumab, Rituximab, and PGG Beta Glucan: A Phase I Clinical Trial

Clinical Utility of PET/CT Scanning in Patients with Chronic Lymphocytic Leukemia

Analysis of Stem Cell Transplant Referral in a Cohort of Newly Diagnosed Chronic Lymphocytic Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only